XBiotech Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
XBiotech Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2013 to Q4 2023.
  • XBiotech Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $17.6M, a 56.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $17.6M +$6.35M +56.6% Dec 31, 2023 10-K 2024-03-15
Q4 2022 $11.2M +$4.75M +73.4% Dec 31, 2022 10-K 2024-03-15
Q4 2021 $6.47M -$1.11M -14.6% Dec 31, 2021 10-K 2023-03-15
Q4 2020 $7.59M +$4.79M +171% Dec 31, 2020 10-K 2022-03-15
Q4 2019 $2.79M -$45.6M -94.2% Dec 31, 2019 10-K 2021-03-16
Q4 2018 $48.4M +$2.66M +5.82% Dec 31, 2018 10-K 2021-03-16
Q4 2017 $45.8M +$5.3M +13.1% Dec 31, 2017 10-K 2020-03-16
Q4 2016 $40.5M +$11.5M +39.8% Dec 31, 2016 10-K/A 2019-03-15
Q4 2015 $29M +$10.3M +55.3% Dec 31, 2015 10-K 2018-03-16
Q4 2014 $18.6M -$10.3M -35.6% Dec 31, 2014 10-K 2017-03-16
Q4 2013 $29M Dec 31, 2013 10-K/A 2016-04-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.